CATALYST DOSSIER · UPDATED 2026-11-20
$LAZ
financials · convergence -2 · conviction WATCH
Price & Live Quote Loading live quote & chart…
Practice trade tools Build a reference frame, save a practice trade, or preview a draft. No brokerage order is placed.
Paper trade unavailable: missing risk-bounded frame
Reference only. Not financial advice. No brokerage order is placed.
Why $LAZ?
Quantitative
Revenue (CY2026Q2) : $830.2M (+160.0% YoY)
Net Income (CY2026Q2) : $4.8M (-91.3% YoY)
Catalysts
Multi-spoke convergence : 8 convergent signals fired: oge_exec, split, fed_overlay, sector_overlay, auto_macro_adp_payrolls
Risks
Position-sizing discipline : Conviction WATCH (-2 score) — size accordingly; no specific catalyst-fade risk flagged
Bear case
Multiple compression : If breadth deteriorates, financials-wide multiples re-rate lower regardless of pick-specific thesis
Sympathy basket (cerebro)
RLX via staples r=+0.96 sympathetic (score 19)
SOWG via staples r=+0.96 sympathetic (score 10)
OMH via real_estate r=+0.87 sympathetic (score 2)
DOUG via real_estate r=+0.87 sympathetic (score 0)
EVRG via utilities r=+0.83 sympathetic (score 21)
VIVK via utilities r=+0.83 sympathetic (score 8)
Signals Firing
oge_exec split fed_overlay sector_overlay auto_macro_adp_payrolls auto_macro_bls_employment auto_macro_credit_spreads auto_macro_durable_goods
Pick Track Record Date List Next-day max run Next-day close Hit +2%? 2026-10-30 sec_top_gappers +3.4% +2.1% ✓ hit 2026-10-30 sec_top_moat_emerging +3.4% +2.1% ✓ hit 2026-10-27 sec_top_gappers +3.6% +0.8% ✓ hit 2026-10-27 sec_top_moat_emerging +3.6% +0.8% ✓ hit
Lifetime: 4/4 wins · hit-rate 100.0% on +2% intraday
Sympathy Basket RLX via staples · score 19 SOWG via staples · score 10 OMH via real_estate · score 2 DOUG via real_estate · score 0 EVRG via utilities · score 21 VIVK via utilities · score 8
Earnings Catalyst No recent earnings event.
Generate full earnings report
Auto-generated from public filings + tier-1 wires. Catalyst Edge publishes its picks
and its losses — see the
trust report and
methodology .
Not financial advice. Confirm independently before trading.